Another 8x Risk to Reward Stock (SBFM)NASDAQ:SBFM
About
Sunshine Biopharma, Inc. is a New York-based pharmaceutical company that develops and commercializes oncology and antiviral drugs, as well as science-based nutritional supplements. Their products include treatments for Coronavirus infections and anticancer drugs. The company w
−19.05USD
−4.51 MUSD
24.09 MUSD
953.39 K
About Sunshine Biopharma Inc.
Sector
CEO
Steve N. Slilaty
Headquarters
New York
Website
Employees (FY)
44
Founded
2006
ISIN
US8677816014
FIGI
BBG000RVLVB7
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in New York, NY.
SBF may not be immune from campaign finance chargesAccording to Coindesk, before Sam Bankman-Fried (SBF) received a criminal trial in October, U.S. prosecutors withdrew charges against him for campaign finance. However, that doesn't mean the DOJ will let SBF go, and campaign finance charges could still come to trial later. The Justice Department sai
$SBFM ♡ SUNSHINE BIOPHARMA INC. ♡ +231.76%My trading plan consists of collecting 5 confirmations MINIMUM on one singular timeframe, across 4 different timeframes (20 total minimum) before I even propose a trading idea to my community.
♡
Disclaimer: Though I take banger trades, you MUST understand the following DISCLAIMER: I am NOT your fi
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SBFM is 3.32 USD — it has decreased by 12.63% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sunshine Biopharma Inc. stocks are traded under the ticker SBFM.
Sunshine Biopharma Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
SBFM stock is 22.58% volatile and has beta coefficient of −0.58. Check out the list of the most volatile stocks — is Sunshine Biopharma Inc. there?
One year price forecast for Sunshine Biopharma Inc. has a max estimate of 300.00 USD and a min estimate of 300.00 USD.
SBFM earnings for the last quarter are −4.00 USD whereas the estimation was −6.00 USD which accounts for 33.33% surprise. Estimated earnings for the next quarter are −3.00 USD. See more details about Sunshine Biopharma Inc. earnings.
Sunshine Biopharma Inc. revenue for the last quarter amounts to 5.96 M USD despite the estimated figure of 6.00 M USD. In the next quarter revenue is expected to reach 6.10 M USD.
Yes, you can track Sunshine Biopharma Inc. financials in yearly and quarterly reports right on TradingView.
SBFM stock has fallen by 66.80% compared to the previous week, the month change is a 37.36% fall, over the last year Sunshine Biopharma Inc. has showed a 95.19% decrease.
SBFM net income for the last quarter is −1.25 M USD, while the quarter before that showed −651.48 K USD of net income which accounts for −91.87% change. Track more Sunshine Biopharma Inc. financial stats to get the full picture.
Today Sunshine Biopharma Inc. has the market capitalization of 3.78 M, it has increased by 18.19% over the last week.
No, SBFM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SBFM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sunshine Biopharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 44.00 employees. See our rating of the largest employees — is Sunshine Biopharma Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sunshine Biopharma Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sunshine Biopharma Inc. stock shows the sell signal. See more of Sunshine Biopharma Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Sunshine Biopharma Inc. future price: according to them, SBFM price has a max estimate of 300.00 USD and a min estimate of 300.00 USD. Read a more detailed Sunshine Biopharma Inc. forecast: see what analysts think of Sunshine Biopharma Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sunshine Biopharma Inc. EBITDA is −4.35 M USD, and current EBITDA margin is −19.24%. See more stats in Sunshine Biopharma Inc. financial statements.